In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...

AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination control, data integrity and operational ...

Decoy Therapeutics, Inc. (Decoy, or the Company), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVstm), a new category of antivirals engineered to work across multiple viruses, ...

Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers ...

When Israeli Defense Minister Israel Katz announced, with the satisfied air of an industrialist surveying demolished ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are ...

Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize ...

Skolnick has developed AI-based approaches to predict protein structure and function that may help with drug discovery and ...

AI-driven interventions reduce the odds of hospitalization within 7 days by 8% in patients with end-stage kidney disease receiving hemodialysis, according to a recent study.

The oral delivery of small-molecule drugs with poor aqueous solubility represents an ongoing drug development challenge. Amorphous solid dispersions (ASDs) and lipid-based formulations (LBFs) have ...